Search hospitals > Illinois > Alton
Saint Anthony's Health
Claim this profileAlton, Illinois 62002
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Lung Cancer
Conducts research for Tumors
193 reported clinical trials
1 medical researcher
Summary
Saint Anthony's Health is a medical facility located in Alton, Illinois. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Lung Cancer, Tumors and other specialties. Saint Anthony's Health is involved with conducting 193 clinical trials across 334 conditions. There are 1 research doctors associated with this hospital, such as Jay W Carlson.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 positive
ER positive
Top PIs
Clinical Trials running at Saint Anthony's Health
Breast Cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Cancer
Lung Cancer
Bladder Carcinoma
Melanoma
Gastric Cancer
Renal Cell Carcinoma
Cutaneous Melanoma
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Sacituzumab Govitecan
for Brain Metastases from Breast Cancer
This study is evaluating whether a combination of a chemotherapy drug and a monoclonal antibody may help treat breast cancer that has spread to the brain.
Recruiting1 award Phase 212 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Anthony's Health?
Saint Anthony's Health is a medical facility located in Alton, Illinois. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Lung Cancer, Tumors and other specialties. Saint Anthony's Health is involved with conducting 193 clinical trials across 334 conditions. There are 1 research doctors associated with this hospital, such as Jay W Carlson.